This could be used, for example, to treat Rett Syndrome where it has been shown, in mice, that reactivation of the inactive wild-type Mecp2 allele in female cells can be beneficial (Guy et al., 2007; Przanowski et al., 2018). Here, MECP2 is linked to atypical Rett syndrome.